Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer

DOI10.1038/S41379-020-0544-XWikidataQ91999916 ScholiaQ91999916MaRDI QIDQ123440FDOQ123440

Authors: Emily S Reisenbichler, Gang Han, Andrew M Bellizzi, Veerle Bossuyt, Jane Brock, Kimberly Cole, Oluwole Fadare, Omar Hameed, Krisztina Hanley, Beth T Harrison, M. Gabriela Kuba, Amy Ly, Dylan Miller, Mirna Podoll, Anja C. Roden, Kamaljeet Singh, Mary Ann Sanders, Shi Wei, Hannah Wen, Vasiliki Pelekanou, Vesal Yaghoobi, Fahad Ahmed, Lajos Pusztai, David L Rimm 

Publication date: September 2020

Published in: Modern Pathology (Search for Journal in Brave)

Cited In (1)

• ONEST

This page was built for publication: Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q123440)